➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Medtronic
Colorcon
McKesson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BOTULINUM TOXIN TYPE B

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for botulinum toxin type b

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004416 Randomized Study of Botulinum Toxin Type A for Achalasia Completed University of Texas N/A 1997-01-01 OBJECTIVES: I. Compare the efficacy of two doses of botulinum toxin in the treatment of achalasia. II. Compare the safety of these two doses in these patients.
NCT00004480 Study of Botulinum Toxin in Patients With Primary Hyperhidrosis Completed Icahn School of Medicine at Mount Sinai N/A 1999-07-01 OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
NCT00015457 Amlodipine Plus Botulinum Toxin for Focal Dystonia Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 2 2001-04-01 Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia. Study Population: 20 patients with cervical dystonia Design: Double-bind, placebo-controlled clinical trail. Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia scale, NINDS subjective patient rating scale), and hand grip strength. For healthy volunteers: Amplitude of EDB MEP.
NCT00060957 Botulinum Toxin (BOTOX) for Cerebral Palsy Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 2 1997-07-01 This study examines botulinum toxin (BOTOX, or BTX) for the treatment of muscle twitches and spasticity associated with cerebral palsy in children. Botulinum toxin is a naturally occurring bacterial toxin (botulinum toxin) that inactivates certain parts of muscles.
NCT00076687 Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function Completed Allergan Phase 2 2003-10-01 The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for botulinum toxin type b

Condition Name

Condition Name for botulinum toxin type b
Intervention Trials
Stroke 19
Cerebral Palsy 19
Overactive Bladder 18
Cervical Dystonia 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for botulinum toxin type b
Intervention Trials
Muscle Spasticity 53
Syndrome 30
Cerebral Palsy 28
Stroke 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for botulinum toxin type b

Trials by Country

Trials by Country for botulinum toxin type b
Location Trials
United States 343
France 52
Canada 51
Germany 33
Taiwan 30
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for botulinum toxin type b
Location Trials
California 45
New York 30
Florida 25
Texas 24
Tennessee 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for botulinum toxin type b

Clinical Trial Phase

Clinical Trial Phase for botulinum toxin type b
Clinical Trial Phase Trials
Phase 4 94
Phase 3 125
Phase 2/Phase 3 23
[disabled in preview] 148
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for botulinum toxin type b
Clinical Trial Phase Trials
Completed 225
Recruiting 110
Not yet recruiting 65
[disabled in preview] 77
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for botulinum toxin type b

Sponsor Name

Sponsor Name for botulinum toxin type b
Sponsor Trials
Allergan 77
Merz Pharmaceuticals GmbH 24
Ipsen 23
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for botulinum toxin type b
Sponsor Trials
Other 532
Industry 192
NIH 20
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
McKinsey
Moodys
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.